NewsDesk  @infectiousdiseasenews The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe...

A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19. The trial launched at the end of March, when the...

The use of the anti-malarial drug, hydroxychloroquine, for the potential treatment of COVID-19, has been one of the most unusual things I’ve observed during this pandemic as it became very political...

Hydroxychloroquine plus azithromycin increases heart risk, finds global study The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including...

Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that...

Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry...

By NewsDesk  @infectiousdiseasenews Brazil’s Health ministry has reported an additional 60,000 COVID-19 cases since June 2,putting the country’s total case count at 614,000. In addition,...

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019...

On Friday, the US Food and Drug Administration (FDA) issued a safety alert concerning the use of hydroxychloroquine or chloroquine for the treatment of COVID-19. FDA is concerned that hydroxychloroquine...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...